In Silico molecular docking evaluation of mangiferin against key colorectal cancer associated proteins
International Journal of Biosciences (IJB) · 05.03.2026 · 22
DOI: 10.12692/ijb/28.3.22-32 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biosciences (IJB), online erschienen am 05.03.2026. Verfasst von Monisha Ravi und 1 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a multifactorial malignancy driven by dysregulated inflammatory signaling, aberrant cell proliferation, defective apoptosis, loss of tumor suppressor functions, and aberrant activation of oncogenic signaling pathways. The identification of multi-target agents capable of simultaneously modulating these interconnected pathways represents a promising therapeutic strategy. In the present study, the multi-target therapeutic potential of mangiferin, a bioactive C-glucosyl xanthone, was systematically evaluated against key CRC-associated molecular targets using structure-based molecular docking. Molecular docking was performed using AutoDock Vina against proteins involved in inflammation (TNF-α and COX-2), proliferation and angiogenesis (K-Ras, BRAF, β-catenin, VEGFR-2, and Cyclin D1), apoptosis (Bcl-2, BAX, and Caspase-3), tumor suppression (p53 and APC), and the PI3K/Akt/mTOR signaling pathway (PI3K-α, AKT, and mTOR). Protein structures were retrieved from the RCSB Protein Data Bank and docked following binding-site prediction using CASTp. Mangiferin exhibited strong to moderate binding affinities toward all selected targets, with docking scores ranging from −10.5 to −7.0 kcal/mol. The strongest binding affinity was observed with TNF-α (−10.5 kcal/mol), followed by AKT (−10.3 kcal/mol), COX-2 (−9.8 kcal/mol), BRAF (−9.4 kcal/mol), and PI3K-α (−9.4 kcal/mol), indicating effective targeting of inflammatory mediators and oncogenic survival signaling pathways. Moderate binding affinities were observed for VEGFR-2 and p53 (−8.5 kcal/mol), K-Ras and APC (−8.4 kcal/mol), and Bcl-2 (−8.2 kcal/mol), suggesting potential inhibition of angiogenesis, cell proliferation, and anti-apoptotic signaling. Additionally, mangiferin demonstrated favorable interactions with β-catenin (−7.7 kcal/mol), caspase-3 (−7.6 kcal/mol), mTOR (−7.5 kcal/mol), BAX (−7.1 kcal/mol), and Cyclin D1 (−7.0 kcal/mol), highlighting its capacity to modulate Wnt signaling, apoptosis, cell-cycle regulation, and PI3K/AKT/mTOR pathway components. Overall, mangiferin–protein complexes were stabilized through a combination of hydrogen bonding and hydrophobic π-interactions, supporting mangiferin as a promising multi-target phytochemical with therapeutic relevance in colorectal cancer.
Zitieren
APA
Ravi, M., & Malarvizhi*, A. (2026). In Silico molecular docking evaluation of mangiferin against key colorectal cancer associated proteins. International Journal of Biosciences (IJB), 22. https://doi.org/10.12692/ijb/28.3.22-32
Vancouver
Ravi M, Malarvizhi* A. In Silico molecular docking evaluation of mangiferin against key colorectal cancer associated proteins. International Journal of Biosciences (IJB). 2026:22. doi:10.12692/ijb/28.3.22-32
BibTeX
@article{Ravi2026,
author = {Ravi, Monisha and Malarvizhi*, A.},
title = {In Silico molecular docking evaluation of mangiferin against key colorectal cancer associated proteins},
journal = {International Journal of Biosciences (IJB)},
year = {2026},
pages = {22},
doi = {10.12692/ijb/28.3.22-32}
}
EUVIMED